Activation of IGF-1 pathway and suppression of atrophy related genes are involved in Epimedium extract (icariin) promoted C2C12 myotube hypertrophy.

The regenerative effect of Epimedium and its major bioactive flavonoid icariin (ICA) have been documented in traditional medicine, but their effect on sarcopenia has not been evaluated. The aim of this study was to investigate the effects of Epimedium extract (EE) on skeletal muscle as represented by differentiated C2C12 cells. Here we demonstrated that EE and ICA stimulated C2C12 myotube hypertrophy by activating several, including IGF-1 signal pathways. C2C12 myotube hypertrophy was demonstrated by enlarged myotube and increased myosin heavy chains (MyHCs). In similar to IGF-1, EE/ICA activated key components of the IGF-1 signal pathway, including IGF-1 receptor. Pre-treatment with IGF-1 signal pathway specific inhibitors such as picropodophyllin, LY294002, and rapamycin attenuated EE induced myotube hypertrophy and MyHC isoform overexpression. In a different way, EE induced MHyC-S overexpression can be blocked by AMPK, but not by mTOR inhibitor. On the level of transcription, EE suppressed myostatin and MRF4 expression, but did not suppress atrogenes MAFbx and MuRF1 like IGF-1 did. Differential regulation of MyHC isoform and atrogenes is probably due to inequivalent AKT and AMPK phosphorylation induced by EE and IGF-1. These findings suggest that EE/ICA stimulates pathways partially overlapping with IGF-1 signaling pathway to promote myotube hypertrophy.

Facile synthesis of highly tunable monodispersed calcium hydroxide composite particles by using a two-step ion exchange reaction.

"Calcium hydroxide [Ca(OH)2]" is a medicament frequently used for antimicrobial purposes in endodontic procedures, or it is used as a toxic-waste adsorbent in industry. Ca(OH)2 particles produced through conventional methods are size untunable and have a wide size distribution and polygonal shape. In this paper, a novel and facile approach involving template-mediated synthesis and two-step ion exchange is proposed for uniform size Ca(OH)2 composite particles generation. "Sodium-alginate (Na-alginate)" was used as a precursor, and monodisperse Na-alginate emulsions were formed through needle droplet or droplet microfluidic technology. After the first ion exchange step with the Ca2+ ions, "calcium-alginate (Ca-alginate)" particles were obtained. The Ca-alginate particles were intermediate reaction products and were designed to be the templates for ensuring the spherical shape and size of products. The OH- ions were used for the second ion exchange step to fabricate Ca(OH)2 composite particles. The results revealed that the Ca(OH)2 composite particles were size tunable, had a spherical shape, and were monodisperse (with a relative standard deviation of less than 8%). The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay revealed that the Ca(OH)2 composite particles were potential biocompatible materials.

Thermal Cycling Effect on Transformation Temperatures of Different Transformation Sequences in TiNi-Based Shape Memory Alloys.

In TiNi-based shape memory alloys (SMAs), the effects of thermal cycling on the transformation peak temperatures of B2 ↔ B19', B2 ↔ R, B2 ↔ B19, B2 ↔ R ↔ B19', and B2 ↔ B19 ↔ B19' one-stage and two-stage transformations have been investigated and compared. Experimental results of the differential scanning calorimeter and hardness tests indicate that the alloy's intrinsic hardness and the shear strain, s, associated with martensitic transformation, are two important factors, due to their relation to the ease of introducing dislocations during cycling. The temperature decrease by cycling for one-stage transformation was in the order of B2 ↔ B19' > B2 ↔ B19 > B2 ↔ R according to the orders of magnitude of their s values. This phenomenon also affected the suppression of B19 ↔ B19' and R ↔ B19' transformation peak temperatures in two-stage transformation. Both Ti50Ni48Fe2 and Ti48.7Ni51.3 SMAs aged at 450 °C for 4 h exhibited B2 ↔ R ↔ B19' transformation, but the hardness of the latter was much higher than that of the former due to the precipitation hardening of the Ti3Ni4 precipitates. This causesd the decrease of the R ↔ B19' transformation peak temperature in the Ti50Ni48Fe2 SMA to be much higher than that in Ti48.7Ni51.3 SMAs aged at 450 °C for 4 h, which directly affected the sequential B2 ↔ R transformation of Ti50Ni48Fe2 SMA in the next thermal cycle and decreased this transformation peak temperature. The Ti48Ni52 SMA aged at 600 °C for 150 h underwent B2 ↔ B19' transformation and then B2 → R → B19'/B19' → B2 transformation as the cycle number increased, in which the B2 ↔ R transformation peak temperature raised slightly by cycling. This characteristic is uncommon and may have resulted from the strain field around the thermal-cycled dislocations favoring the formation of the R-phase.

[Improvement Project Introducing the Hospital Environment to New Patients in Pediatric Wards].

BACKGROUND & PROBLEMS: The pediatric ward in our hospital has an average occupancy rate of ten patients per day. An investigation found that nurses had a low (51.9%) rate of completing the required introduction to the hospital environment for pediatric ward patients. The main reasons for this low rate were found to be: 1) the large number of items to be introduced, 2) interruptions of staffs during the introduction process, 3) the lack of sufficient introduction tools, and 4) patient family members and new caregivers not being given the introduction. PURPOSE: To increase the rate of completeness of nursing staffs introducing the hospital environment from 51.9% to over 91.0%. RESOLUTION: The project team proposed the following solutions. First, make a video introducing the general hospital environment and make it accessible via QR (quick response) code; second, provide multiple introduction video tools; third, make the environment more friendly using ward-mascot-themed décor; fourth, install fixtures in the rooms that complement the ward-mascot theme; fifth, revise the contents of the environment introduction; and sixth, make an environment introduction checklist. RESULTS: The completeness rate of environment introduction increased from 51.9% to 97.6%. CONCLUSIONS: The pediatric ward not only increased the environment introduction completion rate but also created a more friendly environment. Using the video and QR code and providing multiple video players and a checklist has efficiently increased the environment introduction completion rate and, in creating a more friendly environment, has successfully maintained nursing quality.

Ultrasound-Induced Reactive Oxygen Species Mediated Therapy and Imaging Using a Fenton Reaction Activable Polymersome.

Ultrasound techniques have been extensively employed for diagnostic purposes. Because of its features of low cost, easy access, and noninvasive real-time imaging, toward clinical practice it is highly anticipated to simply use diagnostic ultrasound to concurrently perform imaging and therapy. We report a H2O2-filled polymersome to display echogenic reflectivity and reactive oxygen species-mediated cancer therapy simply triggered by the microultrasound diagnostic system accompanied by MR imaging. Instead of filling common perfluorocarbons, the encapsulation of H2O2 in H2O2/Fe3O4-PLGA polymersome provides O2 as the echogenic source and (•)OH as the therapeutic element. On exposure to ultrasound, the polymersome can be easily disrupted to yield (•)OH through the Fenton reaction by reaction of H2O2 and Fe3O4. We showed that malignant tumors can be completely removed in a nonthermal process.

Microfluidic one-step synthesis of Fe3O4-chitosan composite particles and their applications.

This paper demonstrates a simple and easy approach for the one-step synthesis of Fe3O4-chitosan composite particles with tadpole-like shape. The length and diameter of the particles were adjustable from 638.3 µm to ca. 798 µm (length), and from 290 µm to 412 µm (diameter) by varying the flow rate of the dispersed phase. Mitoxantrone was used as the model drug in the drug release study. The encapsulation rate of the drug was 71% for chitosan particles, and 69% for magnetic iron oxide-chitosan particles, respectively. The iron oxide-chitosan composite particles had a faster release rate (up to 41.6% at the third hour) than the chitosan particles (about 24.6%). These iron oxide-chitosan composite particles are potentially useful for biomedical applications, such as magnetic responsive drug carriers, magnetic resonance imaging (MRI) enhancers, in the future.

Synthesis and characterization of oil-chitosan composite spheres.

Oil-chitosan composite spheres were synthesized by encapsulation of sunflower seed oil in chitosan droplets, dropping into NaOH solution and in situ solidification. Hydrophilic materials (i.e., iron oxide nanoparticles) and lipophilic materials (i.e., rhodamine B or epirubicin) could be encapsulated simultaneously in the spheres in a one step process. The diameters of the prepared spheres were 2.48 ± 0.11 mm (pure chitosan spheres), 2.31 ± 0.08 mm (oil-chitosan composites), 1.49 ± 0.15 mm (iron-oxide embedded oil-chitosan composites), and 1.69 ± 0.1 mm (epirubicin and iron oxide encapsulated oil-chitosan composites), respectively. Due to their superparamagnetic properties, the iron-oxide embedded oil-chitosan composites could be guided by a magnet. A lipophilic drug (epirubicin) could be loaded in the spheres with encapsulation rate measured to be 72.25%. The lipophilic fluorescent dye rhodamine B was also loadable in the spheres with red fluorescence being observed under a fluorescence microscope. We have developed a novel approach to an in situ process for fabricating oil-chitosan composite spheres with dual encapsulation properties, which are potential multifunctional drug carriers.

Molecular epidemiology of group A streptococcus causing scarlet fever in northern Taiwan, 2001-2002.

In this study, 830 Streptococcus pyogenes isolates collected between 2001 and 2002 from patients with scarlet fever in northern Taiwan were analyzed by M protein gene (emm) sequence typing, pulsed-field gel electrophoresis (PFGE), and antimicrobial susceptibility testing. A total of 21 emm types and 56 PFGE patterns were identified. The most frequent emm types were emm1 (29.2%), emm4 (24.1%), emm12 (19.0%), emm6 (15.8%), stIL103 (5.7%), and emm22 (1.9%). Antimicrobial resistance profiles were determined, and resistance to erythromycin (24.6%), clindamycin (2.0%), and chloramphenicol (1.3%) was detected. Five major emm types (emm4, emm12, emm1, emm22, and emm6) accounted for 95.6% of the erythromycin-resistant isolates. The decreased prevalence of erythromycin-resistant emm12 strains coincided with the overall decrease in erythromycin resistance from 32.1% in 2001 to 21.1% in 2002 in Taiwan. Five major clones (emm4/2000, emm12/0000, emm4/2010, emm1/1000, and emm22/8100) represented 72.1% of the erythromycin-resistant isolates. The survey of group A Streptococcus emm types, genetic diversity, and antibiotic resistance has direct relevance to current antimicrobial use policies and potential vaccine development strategies.

Surveillance of invasive Streptococcus pneumoniae in Taiwan, 2002-2003.

A total of 522 Streptococcus pneumoniae invasive isolates from diverse sources were collected from January 2002 to December 2003 in Taiwan in order to understand the serotype distribution of invasive isolates in Taiwan. The most frequently isolated serotypes of S. pneumoniae were types 14 (18.4%), 23F (15.1%), 3 (13.8%), 19F (13.4%), 6B (8.2%), 9V (3.6%) and 4 (2.5%). The majority of cases were either under 5 years of age (24.1%) or older than 65 years (36.6%). Serotype distribution in adults aged over 14 years and children aged under 2 years was similar, except for that of type 3, which was more prevalent in adults. Penicillin-non-susceptible strains accounted for 67.7% of all strains and were the predominant strains of serotypes 23F, 19F, 6B and 14. Most strains were susceptible to cephem drug, 85.7% of isolates were susceptible to cefotaxime and 92.9% were susceptible to ceftriaxone. A total of 72.6% (379/522) of the isolates were resistant to at least two antibiotics. The 23-valent vaccine in the current commercial market would cover 87.2% of the serotypes and 100% of the penicillin-non-susceptible serotypes of S. pneumoniae in Taiwan. The coverage of 7- and 11-valent protein conjugate vaccines of the serotypes in children under 2 years of age would be 78.8 and 86.5%, respectively. These results will help to assess the adequacy of the vaccine formulations marketed in Taiwan.